{"id":"https://openalex.org/W7214938706","doi":"https://doi.org/10.3389/fonc.2026.1975159","title":"Loss of CLIC3 in CD8+ cytotoxic T lymphocytes is associated with immune dysfunction and poor prognosis in lung adenocarcinoma","display_name":"Loss of CLIC3 in CD8+ cytotoxic T lymphocytes is associated with immune dysfunction and poor prognosis in lung adenocarcinoma","publication_year":2026,"publication_date":"2026-09-30","ids":{"openalex":"https://openalex.org/W7214938706","doi":"https://doi.org/10.3389/fonc.2026.1975159","pmid":"https://pubmed.ncbi.nlm.nih.gov/42877053","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13662009"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2026.1975159","doi":"https://doi.org/10.3389/fonc.2026.1975159","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1975159","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1975159/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1975159/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5153671023","display_name":"Yinglong Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154093214","display_name":"Xinjiang Medical University","ror":"https://ror.org/01p455v08","country_code":"CN","type":"education","lineage":["https://openalex.org/I154093214"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yinglong Li","raw_affiliation_strings":["Department of Pulmonary Medicine, Affiliated Cancer Hospital of Xinjiang Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pulmonary Medicine, Affiliated Cancer Hospital of Xinjiang Medical University","institution_ids":["https://openalex.org/I154093214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153617596","display_name":"Yidan Nie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154093214","display_name":"Xinjiang Medical University","ror":"https://ror.org/01p455v08","country_code":"CN","type":"education","lineage":["https://openalex.org/I154093214"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yidan Nie","raw_affiliation_strings":["Department of Urology, Affiliated Cancer Hospital of Xinjiang Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Affiliated Cancer Hospital of Xinjiang Medical University","institution_ids":["https://openalex.org/I154093214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153562799","display_name":"Zhigang Han","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154093214","display_name":"Xinjiang Medical University","ror":"https://ror.org/01p455v08","country_code":"CN","type":"education","lineage":["https://openalex.org/I154093214"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhigang Han","raw_affiliation_strings":["Department of Pulmonary Medicine, Affiliated Cancer Hospital of Xinjiang Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pulmonary Medicine, Affiliated Cancer Hospital of Xinjiang Medical University","institution_ids":["https://openalex.org/I154093214"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081675234","display_name":"Tingting Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154093214","display_name":"Xinjiang Medical University","ror":"https://ror.org/01p455v08","country_code":"CN","type":"education","lineage":["https://openalex.org/I154093214"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Tingting Yu","raw_affiliation_strings":["Department of Pulmonary Medicine, Affiliated Cancer Hospital of Xinjiang Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pulmonary Medicine, Affiliated Cancer Hospital of Xinjiang Medical University","institution_ids":["https://openalex.org/I154093214"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5081675234"],"corresponding_institution_ids":["https://openalex.org/I154093214"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.70008461,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":"1975159","last_page":"1975159"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.01759999990463257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.010599999688565731,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clic3","display_name":"CLIC3","score":0.9900000095367432},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.9369999766349792},{"id":"https://openalex.org/keywords/cytotoxic-cd8-t-cells","display_name":"CD8+ cytotoxic T lymphocytes","score":0.9649999737739563},{"id":"https://openalex.org/keywords/t-cell-dysfunction","display_name":"T cell dysfunction","score":0.9739999771118164},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.7860000133514404},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.609000027179718},{"id":"https://openalex.org/keywords/tumor-stage","display_name":"tumor stage","score":0.44699999690055847},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8889999985694885},{"id":"https://openalex.org/keywords/interferon-signaling","display_name":"interferon signaling","score":0.7639999985694885},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.6169999837875366},{"id":"https://openalex.org/keywords/immunotherapy-response","display_name":"immunotherapy response","score":0.6179999709129333},{"id":"https://openalex.org/keywords/single-cell-rna-sequencing","display_name":"single-cell RNA sequencing","score":0.5609999895095825},{"id":"https://openalex.org/keywords/spatial-transcriptomics","display_name":"spatial transcriptomics","score":0.8429999947547913}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.7350999712944031},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.6384999752044678},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.6316999793052673},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5331000089645386},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.5299000144004822},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5067999958992004},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.5012000203132629},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.436599999666214},{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.4327999949455261},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.43220001459121704},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4117000102996826},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.38530001044273376},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35440000891685486},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.3540000021457672},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35109999775886536},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.3449999988079071},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.32260000705718994},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.2994999885559082},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.2976999878883362},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.29339998960494995},{"id":"https://openalex.org/C196166836","wikidata":"https://www.wikidata.org/wiki/Q902926","display_name":"Immunophenotyping","level":3,"score":0.28870001435279846},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.2856999933719635},{"id":"https://openalex.org/C2780339063","wikidata":"https://www.wikidata.org/wiki/Q5201367","display_name":"Cytometry","level":3,"score":0.28360000252723694},{"id":"https://openalex.org/C207886595","wikidata":"https://www.wikidata.org/wiki/Q1456138","display_name":"Pathological","level":2,"score":0.2793000042438507},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.2741999924182892},{"id":"https://openalex.org/C2992881475","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T lymphocyte","level":3,"score":0.26820001006126404},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26600000262260437}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2026.1975159","doi":"https://doi.org/10.3389/fonc.2026.1975159","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1975159","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1975159/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13662009","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13662009/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13662009/pdf/fonc-16-1975159.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:42877053","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42877053","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:4d4d18d343994ac580103775d5daeb69","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/4d4d18d343994ac580103775d5daeb69","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 16 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2026.1975159","doi":"https://doi.org/10.3389/fonc.2026.1975159","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1975159","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1975159/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320322966","display_name":"Xinjiang Medical University","ror":"https://ror.org/01p455v08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214938706.pdf","grobid_xml":"https://content.openalex.org/works/W7214938706.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1493043780","https://openalex.org/W1910012553","https://openalex.org/W1985596675","https://openalex.org/W2043652563","https://openalex.org/W2120375519","https://openalex.org/W2142746235","https://openalex.org/W2588530307","https://openalex.org/W2789011876","https://openalex.org/W2797429263","https://openalex.org/W2952815301","https://openalex.org/W3133880379","https://openalex.org/W4294991991","https://openalex.org/W4297977995","https://openalex.org/W4303621805","https://openalex.org/W4390617792","https://openalex.org/W4406431707","https://openalex.org/W4411191210","https://openalex.org/W4412750182","https://openalex.org/W4416529510","https://openalex.org/W7113901915","https://openalex.org/W7128807508","https://openalex.org/W7135211977","https://openalex.org/W7154824754","https://openalex.org/W7171548252","https://openalex.org/W7203569338"],"related_works":["https://openalex.org/W4298125203","https://openalex.org/W4392465408","https://openalex.org/W4282970356","https://openalex.org/W4387982212","https://openalex.org/W4385520846","https://openalex.org/W4307328098","https://openalex.org/W4394612910","https://openalex.org/W3135400583","https://openalex.org/W7138850315","https://openalex.org/W3096220156"],"abstract_inverted_index":{"Background":[0],"Lung":[1],"adenocarcinoma":[2,93,97],"(LUAD)":[3],"is":[4,68],"the":[5,28,32,65,186,203,221],"most":[6],"common":[7],"histological":[8],"subtype":[9],"of":[10,115,185,263],"lung":[11],"cancer,":[12],"with":[13,100,230,249],"a":[14,143,192,207,212,238,260,289,296],"dismal":[15],"prognosis":[16],"partly":[17],"attributed":[18],"to":[19,128,148,150,169,191,206],"immune":[20],"evasion":[21],"mediated":[22],"by":[23,211],"T":[24,39,61,247,274,285,301],"cell":[25,62,275,302],"dysfunction":[26,276],"within":[27,64],"tumor":[29,77,251,278],"microenvironment.":[30],"However,":[31],"molecular":[33],"determinants":[34],"governing":[35],"CD8":[36,245,283],"+":[37,153,178,246,284],"cytotoxic":[38],"lymphocyte":[40],"functional":[41,132,265],"competence":[42,266],"remain":[43],"incompletely":[44],"understood.":[45],"Chloride":[46],"intracellular":[47],"channel":[48],"3":[49],"(CLIC3)":[50],"has":[51],"been":[52],"implicated":[53],"in":[54,60,88,111,139,214,226,241,267,282,304],"cancer":[55],"progression,":[56],"but":[57],"its":[58,270],"role":[59],"immunity":[63],"LUAD":[66,81,117],"TME":[67],"unknown.":[69],"Methods":[70],"We":[71],"performed":[72],"single-cell":[73],"RNA":[74],"sequencing":[75],"on":[76,244],"tissues":[78],"from":[79,146],"nine":[80],"patients":[82],"spanning":[83],"three":[84],"pathological":[85],"stages":[86],"(adenocarcinoma":[87],"situ":[89],"[AIS],":[90],"minimally":[91],"invasive":[92,96],"[MIA],":[94],"and":[95,107,122,141,166,218,253,269,295],"[IAC]),":[98],"integrated":[99],"spatial":[101],"transcriptomics,":[102],"TCGA-LUAD":[103,227],"bulk":[104],"RNA-seq":[105],"analysis,":[106],"flow":[108],"cytometric":[109],"validation":[110],"an":[112],"independent":[113],"cohort":[114],"32":[116],"patients.":[118],"Functional":[119],"module":[120,158],"scoring":[121],"pseudotime":[123],"trajectory":[124,173],"analysis":[125,174],"were":[126,180,200],"applied":[127],"characterize":[129],"CLIC3-associated":[130],"CTL":[131,264],"states.":[133],"Results":[134],"CLIC3":[135,152,177,197,224,242,257,280],"was":[136,228],"predominantly":[137],"expressed":[138],"CTLs":[140,154],"showed":[142,237],"stage-associated":[144,239,271],"decline":[145,213],"AIS":[147],"MIA":[149],"IAC.":[151],"exhibited":[155],"significantly":[156,231],"higher":[157],"scores":[159],"for":[160,292,299],"cytotoxicity,":[161],"cytoskeleton":[162],"remodeling,":[163],"interferon":[164],"signaling,":[165],"chemotaxis":[167],"compared":[168],"CLIC3-":[170],"CTLs.":[171],"Pseudotime":[172],"indicated":[175],"that":[176],"cells":[179,199,248,286],"positioned":[181,201],"at":[182,202],"one":[183],"end":[184],"inferred":[187],"transcriptional":[188],"continuum,":[189],"corresponding":[190,205],"functionally":[193],"active":[194],"state,":[195,209],"while":[196],"-":[198],"other,":[204],"dysfunctional":[208],"accompanied":[210],"CD247,":[215],"GZMB,":[216],"PRF1,":[217],"TNF":[219],"along":[220],"trajectory.":[222],"High":[223],"expression":[225,243,281],"associated":[229],"longer":[232],"overall":[233],"survival.":[234],"Flow":[235],"cytometry":[236],"decrease":[240],"increasing":[250],"invasiveness":[252],"poor":[254],"differentiation.":[255],"Conclusions":[256],"serves":[258],"as":[259],"novel":[261],"marker":[262],"LUAD,":[268],"downregulation":[272],"reflects":[273],"during":[277],"progression.":[279],"may":[287],"represent":[288],"predictive":[290],"biomarker":[291],"immunotherapeutic":[293],"response":[294],"potential":[297],"target":[298],"restoring":[300],"function":[303],"LUAD.":[305]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2026-10-01T00:00:00"}